Please select the option that best describes you:

Is there enough evidence now to use injectable semaglutide as a foundational therapy for symptomatic heart failure with preserved ejection fraction in the setting of overweight or obesity?  



Answer from: at Academic Institution
Comments
at Yale Medicine
Well outlined Dr. @Albulushi. I would only add tha...
Sign in or Register to read more